newsfilter
← Latest News
GlobeNewswire·

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study

MELBOURNE, Australia, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Immuron Limited ((ASX: IMC, NASDAQ:IMRN), is an Australian based and globally integrated biopharmaceutical company that has developed two commercially available